Articles | Volume 8, issue 1
https://doi.org/10.5194/jbji-8-29-2023
https://doi.org/10.5194/jbji-8-29-2023
Guidelines/recommendations/consensus paper
 | 
12 Jan 2023
Guidelines/recommendations/consensus paper |  | 12 Jan 2023

Guideline for management of septic arthritis in native joints (SANJO)

Christen Ravn, Jeroen Neyt, Natividad Benito, Miguel Araújo Abreu, Yvonne Achermann, Svetlana Bozhkova, Liselotte Coorevits, Matteo Carlo Ferrari, Karianne Wiger Gammelsrud, Ulf-Joachim Gerlach, Efthymia Giannitsioti, Martin Gottliebsen, Nis Pedersen Jørgensen, Tomislav Madjarevic, Leonard Marais, Aditya Menon, Dirk Jan Moojen, Markus Pääkkönen, Marko Pokorn, Daniel Pérez-Prieto, Nora Renz, Jesús Saavedra-Lozano, Marta Sabater-Martos, Parham Sendi, Staffan Tevell, Charles Vogely, Alex Soriano, and the SANJO guideline group
Editorial note: The supplement to this article was adjusted on 2 February 2023. The section "Workshop report 7" was shortened.

Viewed

Total article views: 6,487 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
4,710 1,643 134 6,487 359 57 61
  • HTML: 4,710
  • PDF: 1,643
  • XML: 134
  • Total: 6,487
  • Supplement: 359
  • BibTeX: 57
  • EndNote: 61
Views and downloads (calculated since 12 Jan 2023)
Cumulative views and downloads (calculated since 12 Jan 2023)

Viewed (geographical distribution)

Total article views: 6,126 (including HTML, PDF, and XML) Thereof 6,126 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 23 Dec 2024
Download

Please read the editorial note first before accessing the article.

Short summary
Management of septic arthritis in native joints (SANJO) is often conducted by clinicians of different specialties, experience levels, and at all hours of the day. The SANJO guideline group makes evidence-based recommendations for diagnosis, microbiological investigation, initial surgery, empirical antibiotic treatment, early mobilization, evaluation of outcomes, and treatment failure. Special considerations were made for children, tuberculosis, and SANJO after cruciate ligament reconstruction.